semaglutide shortage ending Ozempic and Wegovy are no longer in shortage, FDA says Compounded' weight-loss drugs are a

Keep SDS binders accessible at all times and conduct regular safety drills for spill response

This convergence of unmet demand and commercial supply has driven individuals toward alternative channels, says Peter Goulden, MD, FRCP, division chief of the division of endocrinology, diabetes, and bone diseases at Mount Sinai

Wegovy has generated demand so explosive it has prompted manufacturing shortages, insurer pushback, and social media bans on celebrities and influencers promoting it

While branded products undergo the full FDA approval process with Phase I through Phase III clinical trials, compounded versions operate under a different regulatory framework

Patients on the GLP-1 program have reported mixed experiences with provider availability